← FDA Drug Approvals (Drugs@FDA)

PALONOSETRON HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-09-19

Drug application

FDA Application #

ANDA206396

Application type

Abbreviated New Drug Application (Generic)

Brand name

PALONOSETRON HYDROCHLORIDE

Generic name

Palonosetron Hydrochloride

Active ingredients

PALONOSETRON HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

CIPLA

First approval

2018-09-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown